EUVIMEDEUVIMED entdecken
Crossref

BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation

Peipei Zhang, Weiguang Zhang, Xiaoqing Wang, Lingling Li, Ye Lin, Ningzi Wu, Renyan Mao, Jihong Lin, Mingqiang Kang, Chen Ding

Cancer Letters · 2024-06 · 591 · 216874

DOI: 10.1016/j.canlet.2024.216874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2024-06. Verfasst von Peipei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China. Hauptthemen laut MEDLINE: Cell Proliferation, Disease Progression, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Fudan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal cancer ranks among the most prevalent malignant tumors, and esophageal squamous cell carcinoma (ESCC) constitutes its predominant histological form. Despite its impact, a thorough insight into the molecular intricacies of ESCC's development is still incomplete, which hampers the advancement of targeted molecular diagnostics and treatments. Recently, B-cell lymphoma-2-associated transcription factor 1 (BCLAF1) has come under investigation for its potential involvement in tumor biology, yet its specific role and mechanism in ESCC remain unclear. In this study, we observed a marked increase in BCLAF1 expression in ESCC tissues, correlating with advanced tumor stages and inferior patient outcomes. Our comprehensive in vitro and in vivo studies show that BCLAF1 augments glycolytic activity and the proliferation, invasion, and spread of ESCC cells. By employing mass spectrometry, we identified YTHDF2 as a key protein interacting with BCLAF1 in ESCC, with further validation provided by colocalization, co-immunoprecipitation, and GST pull-down assay. Further investigations involving MeRIP-seq and RIP-seq, alongside transcriptomic analysis, highlighted SIX1 mRNA as a molecule significantly upregulated and modified by N6-methyladenosine (m6A) in BCLAF1 overexpressing cells. BCLAF1 was found to reduce the tumor-suppressive activities of YTHDF2, and its effects on promoting glycolysis and cancer progression were shown to hinge on SIX1 expression. This research establishes that BCLAF1 fosters glycolysis and tumor progression in ESCC through the YTHDF2-SIX1 pathway in an m6A-specific manner, suggesting a potential target for future therapeutic intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationDisease ProgressionEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaGene Expression Regulation, NeoplasticRNA StabilityRNA-Binding ProteinsRepressor ProteinsHomeodomain ProteinsAnimalsFemaleHumansMaleMiceAdenosineCell Line, TumorCell MovementGlycolysisMice, NudeRNA, MessengerTumor Suppressor Proteins

Stichwörter der Autor:innen

BCLAF1ESCCSIX1YTHDF2m(6)A modification

Substanzen

AdenosineRNA, MessengerRNA-Binding ProteinsBCLAF1 protein, humanYTHDF2 protein, humanSIX1 protein, humanRepressor ProteinsTumor Suppressor ProteinsHomeodomain Proteins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China.
  • State Key Laboratory of Genetic Engineering and Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Institutes of Biomedical Sciences, Human Phenome Institute, Fudan University, Shangh…
  • Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, 350001, China; Department of Cardiothoracic Surgery, Affiliated Hospital of Putian University, Putian, 351100, China; Key Laboratory of G…

Förderung

  • Fudan University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, P., Zhang, W., Wang, X., Li, L., Lin, Y., Wu, N., Mao, R., Lin, J., Kang, M., & Ding, C. (2024). BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation. Cancer Letters, 591, 216874. https://doi.org/10.1016/j.canlet.2024.216874

Vancouver

Zhang P, Zhang W, Wang X, Li L, Lin Y, Wu N, et al. BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation. Cancer Letters. 2024;591:216874. doi:10.1016/j.canlet.2024.216874

BibTeX
@article{Zhang2024,
  author = {Zhang, Peipei and Zhang, Weiguang and Wang, Xiaoqing and Li, Lingling and Lin, Ye and Wu, Ningzi and Mao, Renyan and Lin, Jihong and Kang, Mingqiang and Ding, Chen},
  title = {BCLAF1 drives esophageal squamous cell carcinoma progression through regulation of YTHDF2-dependent SIX1 mRNA degradation},
  journal = {Cancer Letters},
  year = {2024},
  volume = {591},
  pages = {216874},
  doi = {10.1016/j.canlet.2024.216874}
}
Kostenlos starten →